TARGETED PROTEIN DEGRADATION

Kurt Gish, Ph.D., is CSO and Co-Founder of Trilo Therapeutics. 

 

His presentation at the 2nd Annual Targeted Protein Degradation Summit

may be downloaded here.  

 

Note, this presentation is intended for attendees only,

so please do not distribute or repost this copyrighted material.